| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6afbd19f560437f5d406b637c676c322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b603ecd95b3b1497ae9f30752a676c0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate |
2016-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d145a5776f68bac86e0b19e1b457271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_253be1ddf51b7deb7975aac663479c18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05def57910729789103c72d20c612fed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e022b2bbca1c52aacb0ffeab73b4917 |
| publicationDate |
2021-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2805743-T3 |
| titleOfInvention |
Method and pharmaceutical composition for use in the treatment of diabetes |
| abstract |
(Pyr1) apelin-13 for use in the treatment or prevention of diabetes in humans, where (Pyr1) apelin-13 is administered to a subject in need of it at a concentration ranging from 10 nmol / kg to 200 nmol / kg per day. |
| priorityDate |
2015-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |